Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.03
+0.11 (0.05%)
AAPL  266.38
-6.57 (-2.41%)
AMD  198.45
-5.23 (-2.57%)
BAC  49.77
-2.53 (-4.84%)
GOOG  305.50
-1.65 (-0.54%)
META  639.67
-17.34 (-2.64%)
MSFT  393.87
-7.85 (-1.95%)
NVDA  178.88
-6.01 (-3.25%)
ORCL  143.49
-6.82 (-4.54%)
TSLA  399.31
-9.27 (-2.27%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.